Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

20.44
+0.48002.40%
Post-market: 20.800.3600+1.76%16:50 EST
Volume:726.33K
Turnover:14.73M
Market Cap:927.37M
PE:10.07
High:20.60
Open:19.67
Low:19.54
Close:19.96
52wk High:31.26
52wk Low:19.54
Shares:45.37M
Float Shares:34.22M
Volume Ratio:0.70
T/O Rate:2.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.03
EPS(LYR):2.03
ROE:12.90%
ROA:6.37%
PB:1.18
PE(LYR):10.07

Loading ...

Aug 16, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Major Issues Report

8-K - Current report